US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Pacific ex Japan ETF

56.22

-0.8900-1.56%

Post-market: 56.220.00000.00%16:15 EDT

Volume:158.53K

Turnover:8.92M

Market Cap:2.26B

PE:6.62

High:56.45

Open:56.34

Low:56.12

Close:57.11

52wk High:58.56

52wk Low:48.93

Shares:40.20M

Float Shares:40.20M

Volume Ratio:1.09

T/O Rate:0.39%

Dividend:1.90

Dividend Rate:3.39%

EPS(TTM):8.50

EPS(LYR):8.50

ROE:25.94%

ROA:1.81%

PB:1.05

PE(LYR):6.62

Loading ...

Overview Company News Filings

Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile

Clinuvel Showcases AI Vitiligo Tool and EPP Therapy at Major U.S. Dermatology Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/EPP/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","market":"US","secType":"STK","nameCN":"iShares MSCI Pacific ex Japan ETF","latestPrice":56.22,"timestamp":1789070400000,"preClose":57.11,"halted":0,"volume":158530,"hourTrading":{"tag":"盘后","latestPrice":56.22,"preClose":56.22,"latestTime":"16:15 EDT","volume":1958,"amount":110078.76,"timestamp":1789071300344,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015583960777447042,"floatShares":40200000,"shares":40200000,"eps":8.495214,"marketStatus":"Post-Mkt","change":-0.89,"latestTime":"09-10 17:49:06 EDT","open":56.34,"high":56.45,"low":56.12,"amount":8921552,"amplitude":0.005778,"askPrice":64.5,"askSize":100,"bidPrice":48.49,"bidSize":100,"shortable":3,"etf":1,"ttmEps":8.495214,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":57.11,"sharesOutstanding":38400000,"nav":57.848266,"aum":2325500293.2,"dividendRate":0.033874,"bidAskSpread":0.000198,"preHourTrading":{"tag":"盘前","latestPrice":57.11,"preClose":57.11,"latestTime":"07:36 EDT","volume":1,"amount":57.11,"timestamp":1789040161205,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":56.22,"preClose":56.22,"latestTime":"16:15 EDT","volume":1958,"amount":110078.76,"timestamp":1789071300344,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.093114,"impliedVol":0.1036,"impliedVolPercentile":0.4183},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","floatShares":40200000,"roa":"1.81%","roe":"25.94%","lyrEps":8.495214,"volumeRatio":1.093114,"shares":40200000,"dividePrice":1.904369,"high":56.45,"amplitude":0.005778,"preClose":57.11,"low":56.12,"week52Low":48.93,"pbRate":"1.05","psRate":"32.98","week52High":58.555,"institutionHeld":0,"latestPrice":56.22,"eps":8.495214,"divideRate":0.033874,"volume":158530,"delay":0,"ttmEps":8.495214,"open":56.34,"prevYearClose":50.47,"prevWeekClose":58.3,"prevMonthClose":57.79,"prevQuarterClose":53.26,"fiveDayClose":57.81,"twentyDayClose":57.4,"sixtyDayClose":53.89},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPP\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"EPP","amount":0.824127,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"EPP","amount":1.045605,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"EPP","amount":0.858764,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"EPP","amount":0.96746,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"EPP","amount":0.70131,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPP\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.90607,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.756156,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.867553,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":1.166804,"currency":"USD"},{"executeDate":"2019-06-17","recordDate":"2019-06-18","paymentDate":"2019-06-21","value":0.842441,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EPP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPP\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633948138","title":"Press Release: Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948138?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:30","pubTimestamp":1777984200,"startTime":"0","endTime":"0","summary":"-- Completed enrollment of the Phase 3 APOLLO study of bitopertin in. erythropoietic protoporphyria ; topline data expected in Q4 2026. -- Updated data from Phase 2 study of DISC-0974 in patients with anemia of. myelofibrosis  to be shared at the American Society of Clinical. -- Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera . and Phase 1b study of DISC-3405 in sickle cell disease , with data. cash, cash equivalents, and marketable securities, providing runway into. adults and adolescents with EPP, with topline data expected Q4 2026;anemia of myelofibrosis  to be shared in an oral presentation at ASCO. -- Progressing Phase 2 study in patients with inflammatory bowel disease","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBD","BK4582","BK4139","EPP","LU0053671581.USD","IRON","SCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629926808","title":"CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study","url":"https://stock-news.laohu8.com/highlight/detail?id=2629926808","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629926808?lang=en_us&edition=fundamental","pubTime":"2026-04-24 13:47","pubTimestamp":1777009620,"startTime":"0","endTime":"0","summary":"“Totality of evidence” approach to evaluate SCENESSEEXECUTIVE SUMMARY final European scientific advice received for pivotal Phase III vitiligo studyEMA emphasised its “totality of evidence” approachce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/24/3280522/0/en/CLINUVEL-receives-final-EMA-scientific-advice-for-pivotal-Phase-III-vitiligo-study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFB","EMA","EPP","BK4087","BK4582","CHMP","BK4134","III","BK4211","BK4081"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627840160","title":"CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627840160","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627840160?lang=en_us&edition=fundamental","pubTime":"2026-04-15 14:18","pubTimestamp":1776233880,"startTime":"0","endTime":"0","summary":"AAD 2026 reinforces CLINUVEL’s expertise in dermatology. Step inside CLINUVEL’s Pavilion of Photomedicine and experience the energy of AAD 2026 through an exclusive video featuring behind-the-scenes of construction, expert insights from the CLINUVEL team and immersive visuals of guests engaging within the Pavilion.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/15/3274140/0/en/CLINUVEL-advancing-peptides-for-photomedicine-and-vitiligo-care-at-AAD-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","EPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624526648","title":"Clinuvel Leverages AAD 2026 to Advance Vitiligo, EPP Strategy and U.S. Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2624526648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624526648?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:29","pubTimestamp":1775093349,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals ( ($AU:CUV) ) has issued an announcement. Clinuvel used the 2026 American Academy of Dermatology Annual Meeting in Denver ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clinuvel-leverages-aad-2026-to-advance-vitiligo-epp-strategy-and-u-s-profile?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clinuvel-leverages-aad-2026-to-advance-vitiligo-epp-strategy-and-u-s-profile?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPP","BK4582"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622989400","title":"Clinuvel Showcases AI Vitiligo Tool and EPP Therapy at Major U.S. Dermatology Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2622989400","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622989400?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:03","pubTimestamp":1774562622,"startTime":"0","endTime":"0","summary":"An announcement from Clinuvel Pharmaceuticals ( ($AU:CUV) ) is now available. Clinuvel Pharmaceuticals is showcasing its melanocortin-based program...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/clinuvel-showcases-ai-vitiligo-tool-and-epp-therapy-at-major-u-s-dermatology-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/clinuvel-showcases-ai-vitiligo-tool-and-epp-therapy-at-major-u-s-dermatology-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIX","BK4582","CHAT","EPP","AIPO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":105,"code":"91000000","status":"200"}]}}